At a glance
ClinicalIndex Comparison Record- ✓Age 40 years or older
- ✓Using a maintenance respiratory medication
- ✓Diagnosis of asthma and/or COPD
- ✓No spirometry test in the past 3 years
- ✕Unable to perform adequate spirometry
- ✕Non-English speaking
- ✕Pregnant
- ✕Planning to move from Chicago area within the next year
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
In Brief
A Phase 3 clinical trial evaluating Spirometry at initial visit, Albuterol, and 1 other intervention for COPD Asthma. Completed, enrolled 402 participants across 2 sites.
Detailed Summary
The purpose of this study is to evaluate the use of spirometry in identifying Diagnostic Error in COPD and Asthma patients.
Study Details
Timeline
Interventions
Initial visit for the intervention group, an initial demographics form and health questionnaires. To evaluate the breathing, a pre and post broncho dilator will be performed as well as a spirometry test.
The post broncho dilator spirometry test will be preformed after a breathing medication called Albuterol. Albuterol is used in standard practice for COPD and is commonly used during spirometry.
At the end of the 1 year followup, the patient will be scheduled for a pre and post BD spirometry test and undergo the same spirometry protocol as the intervention group.